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LIVER TRANSPLANTATION IN PATIENTS OVER SIXTY YEARS OF AGE 1,2 
Orthotopic liver transplantation has been considered the 
accepted form of therapy for a number of end-stage liver 
diseases for several years (1). Until the early 1980s, the unof-
ficially accepted limit for OL TX candidates was 50 years of 
age. 
Although a recent UNOS report seems to suggest that the 
survival of older patients with OL TX is poorer than that of the 
general adult transplant population (2), we have previously 
reported excellent preliminary results with OL TX in patients 
over 50 years of age (3). We have now expanded our series to 
156 patients over 60 years of age at the time they received their 
transplant, and the results are reported here. Our study indi-
cates that results after liver transplantation in patients over 60 
years of age are comparable to the results obtainable in other 
age groups and that advanced age per se is not a contraindica-
tion to liver transplantation. 
Between January 1, 1985 and November 30, 1989, 1475 
patients underwent OL TX at the University of Pittsburgh. 
There were 125 (8.5%) infants (under 2 years of age), 229 
(15.5%) children (between 2 and 18 years of age), 965 (65.4%) 
adults, and 156 (10.6%) seniors (over 60 years of age) (Fig. lA). 
Of the 156 senior patients, 80 were males (51.3%), and 76 
were females (48.7%). One hundred fifty-two patients (97.4%) 
were in the seventh decade of their life, while 4 patients (2.6%) 
were in the eighth decade. Forty-nine patients (31.4%) were 
UNOS class 1 (out of hospital) at the time of the operation, 62 
(39.7%) were class 2 (in the hospital), 24 (15.4%) were class 3 
(in the intensive care unit), and 21 (13.5%) were class 4 (urgent) 
(Fig. IB). Of the entire group, 129 patients (82.7%) received 
one graft, 26 patients (16.7%) 2 grafts, and 1 patient (0.6%) 
received 3 grafts (Fig. lC). 
The indications for transplantation were: postnecrotic cir-
rhosis (PNC)* 65 (41.7%); primary biliary cirrhosis (PBC) 40 
(25.6%); primary hepatic malignancy (CA) 19 (12.2%); alcoholic 
cirrhosis (ETOH) 17 (10.9%); primary sclerosing cholangitis 
(PSC) 6 (3.8%); metabolic disorders (MET) 5 (3.2%); acute 
hepatic failure (AHF) 2 (1.3%); and miscellaneous (OTH) 2 
(1.3%) (Fig. lD). 
Actuarial survival analysis was performed using the lL mod-
ule of BMDP/PC, 1988 release (BMDP Statistical Software, 
Los Angeles, CAl on an IBM-PC compatible microcomputer. 
Differences were considered significant if P <0.05 and highly 
significant if P <0.01. 
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The actuarial survival rates (life-table method) for patients 
with primary grafts was 71.3% after 1 year and 65.5% after 3 
years. By comparison, the adult survival ranges were 78% and 
71.4%, respectively (Fig. 2A). 
For retransplantations, the senior survival rates were 50% at 
1 year and 30.7% at 3 years. By comparison, the adult survival 
rates were 56% and 43.1%, respectively (Fig. 2B). When the 
UNOS status was considered, the survival was significantly 
worse for class 4 (P <0.02) (Fig. 2C). 
Of the survivors, 66 (66.7%) are fully functional (status 1); 
27 (27.3%) are functional with some limitation (status 11); 5 
(5.0%) are partially disabled and in need of some assistance 
(status III); and 1 (1.0%) is disabled and needing full-time 
assistance (status IV) (Fig. 3A). 
The senior group had characteristics similar to the general 
adult liver transplant population, with the exception of age. 
This includes primary liver disease, male/female ratio, and 
medical urgency status (UNOS class). 
The overall survival for the senior group compared favorably 
with that of the infant and adult groups. The adult group was 
used for comparison as a "standard" for survival, while the 
infants were used as another "high-risk" group. The positive 
results with the older age population may come as a surprise at 
first glance, but to us it is clear that the physiological age is 
vastly more important than the chronological age toward sur-
vival. Our oldest recipient was 76 years old when she was given 
a transplant for PBC, and is still well and an active grand-
mother at 4 years later. In fact, over the years, the number of 
transplants in older patients has proportionally increased, com-
pared to those in the adult population, as we have become more 
confident of achieving good results in this patient population 
(Fig. 3B). 
As anticipated, the survival for the much sicker patients in 
class 4 was statistically poorer. This is consistent with previous 
observations of a correlation between preoperative patient con-
dition and survival with OLTX (4, 5). 
The preoperative evaluation of the older OL TX candidates 
is similar to that of the general population, although sometimes 
it may be more complex, as it is more frequently necessary to 
study the cardiopulmonary condition in greater detail. But once 
severe concurrent conditions have been ruled out, the prognosis 
is as good as that for the general adult population. Many of 
these patients, especially those with primary biliary cirrhosis, 
present with advanced hepatic osteopathy that is often the 
rate-limiting pathology for recuperation after liver transplan-
tation. This is one of the reasons for which we advocate early 
referral and transplantation for such patients, before the crip-
pling effects of advanced and irreversible bone disease have set 
in. It is frequently possible and often important to use less-
aggressive steroid regimens for immunosuppression in these 
older patients, in order to avoid worsening of the osteopathy, 
onset of steroid-dependent diabetes, and cataracts. As in the 
rest of the surgical population, early mobilization is extremely 
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FIGURE 1. (A) OL TX by age group; (B) senior OLTX population 
distribution by class; (C) senior OL TX population distribution by graft 
number; and (D) senior OL TX population distribution by diagnosis. 
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FIGURE 2. (A) Patient survival (primary graft); (B) patient survival 
(retransplants); and (Cl senior OLTX population survival by UNOS 
class. 
important. Otherwise, the postoperative care does not differ 
significantly from the "standard." 
A large percentage of the older patients do recuperate com-
pletely or almost completely (93.9% of the survivors in our 
series have a functional status I or II) and can be active and 
productive again. Besides assuring them satisfactory quality for 
the rest of their lives, liver transplantation has the potential to 
increase the pool of productive population, in an era in which 
there will be an ever· higher percentage of elderly persons who 
retire late or reenter the job market. 
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FIGURE 3. (A) Senior OLTX population; functional status; and (B) 
senior OLTX population by year. 
We conclude that advanced age is not a contraindication to 
liver transplantation. The results after liver transplantation in 
patients over the age of 60 were comparable to results for the 
general transplant population. These statistics were in contrast 
to the recent UNOS report for the calendar year 1988, during 
which the I-year mortality rate was 50% for patients 65 years 
or older (2). 
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DISCUSSION 
DR. SHAW (Omaha, Nebraska): Have you noticed any dif-
ference in the frequency or severity of rejection episodes in 
older patients? We certainly noticed that in a series of patients 
over 65 years of age, for instance, that their hospital course and 
the number and severity of rejection episodes, seems to be a bit 
less than the rest of the population. 
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DR. STIEBER: Their immune system is probably more 
depressed to begin with. We observed a lower incidence of 
episodes of rejection, which was not statistically significant, 
though. On the other hand, they have to spend maybe a few 
days longer in the leU on a respirator, about a week longer in 
the hospital. So that compensates a little bit for the lower 
incidence of rejection. 
DR. WALL: (London, Ontario): In the cardiac workup of 
your patients are you satisfied with 3-D echoes in assessing 
ventricular function or do you do angiography? 
DR. STIEBER: Well, we usually do the echo and the MUGA 
scan. If the MUGA scan is abnormal, then we proceed with an 
angiography. But the angiography is not done as a routine by 
any means. 
DR. WALL: And have you performed liver transplants on 
any patients who've had angina or who've been on Digoxin to 
treat congestive heart failure? 
DR. STIEBER: No. 
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